Status:
UNKNOWN
Antenatal Tranexamic Acid in Women With Symptomatic Placenta Previa
Lead Sponsor:
Ain Shams University
Conditions:
Placenta Previa
Eligibility:
FEMALE
20-40 years
Phase:
PHASE2
PHASE3
Brief Summary
200 pregnant women with symptomatic placenta previa with previous bleeding attacks attending Ain Shams University maternity hospital will be recruited and randomized to receive either tranexamic acid ...
Eligibility Criteria
Inclusion
- Gestational age 28 weeks of gestation.
- Definite and reliable diagnosis of placenta previa (defined as presence of a placenta within 2 cm of the internal os), using transvaginal ultrasound scan.
- Haemodynamically stable pregnant women.
- Maternal age:20-40years old.
- Pregnant women with placenta previa, and had previous bleeding attacks or admitted with antepartum haemorrhage.
Exclusion
- Multiple pregnancy.
- Women with bleeding tendency due to any medical disorder (ITP, thrombocytopenia, coagulopathies),or on anticoagulants .
- Severe antepartum hemorrhage and/or hemodynamic instability that necessitates urgent intervention and delivery.
- Women have hypersensitivity or any contraindication to use of tranexamic acid.
- Pregnant women with placenta previa with doppler showing morbidly adherent placenta.
Key Trial Info
Start Date :
August 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04055194
Start Date
August 1 2019
End Date
August 1 2020
Last Update
August 13 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain SHams Maternity Hospital
Cairo, Abbaseya, Egypt, 002